CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance

被引:31
|
作者
Zhao, Gexin [1 ]
Huang, Bau-Lin [2 ]
Rigueur, Diana [1 ]
Wang, Weiguang [1 ]
Bhoot, Chimay [1 ]
Charles, Kemberly R. [1 ]
Baek, Jongseung [1 ,3 ]
Mohan, Subburaman [4 ,5 ]
Jiang, Jie [1 ,6 ,7 ]
Lyons, Karen M. [1 ,3 ,7 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA
[2] NCI, Ctr Canc Res, Frederick, MD 21701 USA
[3] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA
[4] Jerry L Pettis Mem VA Med Ctr, Musculoskeletal Dis Ctr, Loma Linda, CA USA
[5] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA
[6] Univ Calif Los Angeles, Sch Dent, 615 Charles E Young Dr South,Room 546, Los Angeles, CA 90095 USA
[7] Hemophilia Treatment Ctr, Orthopaed Inst Children, Los Angeles, CA USA
关键词
GENETIC ANIMAL MODELS; ANIMAL MODELS; MOLECULAR PATHWAYS; REMODELING; BONE MODELING AND REMODELING; WNT; BETA-CATENIN; LRPS; CELL; TISSUE SIGNALING; PARACRINE PATHWAYS; OSTEOCYTES; CELLS OF BONE; ENDOTHELIAL-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; RECEPTOR-RELATED PROTEIN-5; MATRICELLULAR PROTEIN; BETA-CATENIN; OSTEOBLAST DIFFERENTIATION; SKELETAL DEVELOPMENT; TARGETED DELETION; GENE-EXPRESSION; CRE RECOMBINASE;
D O I
10.1002/jbmr.3394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CYR61/CCN1 is a matricellular protein that resides in the extracellular matrix, but serves regulatory rather than structural roles. CYR61/CCN1 is found in mineralized tissues and has been shown to influence bone healing in vivo and osteogenic differentiation in vitro. In this study we generated Cyr61 bone-specific knockout mice to examine the physiological role of CYR61/CCN1 in bone development and maintenance in vivo. Extensive analysis of Cyr61 conditional knockout mice showed a significant decrease in both trabecular and cortical bone mass as compared to WT littermates. Our data suggest that CYR61/CCN1 exerts its effects on mature osteoblast/osteocyte function to modulate bone mass. Specifically, changes were observed in osteocyte/osteoblast expression of RankL, VegfA, and Sost. The increase in RankL expression was correlated with a significant increase in osteoclast number; decreased VegfA expression was correlated with a significant decrease in bone vasculature; increased Sost expression was associated with decreased Wnt signaling, as revealed by decreased Axin2 expression and increased adiposity in the bone marrow. Although the decreased number of vascular elements in bone likely contributes to the low bone mass phenotype in Cyr61 conditional knockout mice, this cannot explain the observed increase in osteoclasts and the decrease in Wnt signaling. We conducted in vitro assays using UMR-106 osteosarcoma cells to explore the role CYR61/CCN1 plays in modulating Sost mRNA and protein expression in osteocytes and osteoblasts. Overexpression of CYR61/CCN1 can suppress Sost expression in both control and Cyr61 knockout cells, and blocking Sost with siRNA can rescue Wnt responsiveness in Cyr61 knockout cells in vitro. Overall, our data suggest that CYR61/CCN1 modulates mature osteoblast and osteocyte function to regulate bone mass through angiogenic effects as well as by modulating Wnt signaling, at least in part through the Wnt antagonist Sost. (c) 2018 American Society for Bone and Mineral Research.
引用
收藏
页码:1076 / 1089
页数:14
相关论文
共 50 条
  • [1] CCN1 (CYR61): Two faces in cancer
    不详
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (05) : 473 - 474
  • [2] The Roles of CCN1/CYR61 in Pulmonary Diseases
    Zhu, Yin
    Almuntashiri, Sultan
    Han, Yohan
    Wang, Xiaoyun
    Somanath, Payaningal R.
    Zhang, Duo
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 16
  • [3] Functional properties and intracellular signaling of CCN1/Cyr61
    Chen, Ying
    Du, Xiao-Yan
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (06) : 1337 - 1345
  • [4] CCN1/CYR61: the very model of a modern matricellular protein
    Lester F. Lau
    [J]. Cellular and Molecular Life Sciences, 2011, 68 : 3149 - 3163
  • [5] Cyr61/CCN1 regulates SHh through Notch signaling in pancreatic cancer cells
    Haque, Inamul
    Majumder, Monami
    Banerjee, Sushanta K.
    Mehta, Smita
    Banerjee, Snigdha
    [J]. CANCER RESEARCH, 2012, 72
  • [6] Expression, purification, and functional testing of recombinant CYR61/CCN1
    Schütze, N
    Kunzi-Rapp, K
    Wagemanns, R
    Nöth, U
    Jatzke, S
    Jakob, F
    [J]. PROTEIN EXPRESSION AND PURIFICATION, 2005, 42 (01) : 219 - 225
  • [7] The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
    Todorovic, V
    Chen, CC
    Hay, N
    Lau, LF
    [J]. JOURNAL OF CELL BIOLOGY, 2005, 171 (03): : 559 - 568
  • [8] CYR61 (CCN1) is essential for placental development and vascular integrity
    Mo, FE
    Muntean, AG
    Stolz, DB
    Watkins, SC
    Lau, LF
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 419A - 419A
  • [9] CYR61 (CCN1) overexpression induces lung injury in mice
    Grazioli, Serge
    Gil, Sucheol
    An, Dowon
    Kajikawa, Osamu
    Farnand, Alex W.
    Hanson, Josiah F.
    Birkland, Timothy
    Chen, Peter
    Duffield, Jeremy
    Schnapp, Lynn M.
    Altemeier, William A.
    Matute-Bello, Gustavo
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 308 (08) : L759 - L765
  • [10] CCN1/CYR61: the very model of a modern matricellular protein
    Lau, Lester F.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (19) : 3149 - 3163